Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,138.80
-0.5%
-35.11
Arrow-Thin-Down
DJI
49,141.93
-0.1%
-25.86
Arrow-Thin-Down
NASDAQ
24,663.80
-0.9%
-223.30
Arrow-Thin-Down
Bitcoin
$76,373.00
-0.9%
-$732.23
Arrow-Thin-Down
AAPL
$270.83
+1.2%
+$3.22
Arrow-Thin-Down
AMZN
$259.70
-0.5%
-$1.42
Arrow-Thin-Down
GOOG
$347.55
-0.3%
-$0.97
Arrow-Thin-Down
META
$671.34
-1.1%
-$7.28
Arrow-Thin-Down
MSFT
$429.55
+1.1%
+$4.73
Arrow-Thin-Down
NVDA
$213.48
-1.4%
-$3.13
Arrow-Thin-Down
TSLA
$376.32
-0.6%
-$2.35
Most Active StocksDaily Stock GainersDaily Stock Losers

First Tracks Biotherapeutics

(NASDAQ) TRAX

Current Price$20.05
Market CapN/A
Since IPO (2026)-5%
5 YearN/A
1 YearN/A
1 MonthN/A

First Tracks Biotherapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

5.91 (High)

Price

$20.05

Volume

572,361

Open

$17.44

Previous Close

$20.05

Daily Range

$17.44 - $21.66

52-Week Range

$14.79 - $26.80

TRAX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About First Tracks Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Headquarters

San Diego, US

TRAX Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

572.36K

Avg. Volume

275.53K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

First Tracks Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7136.82-0.01%
^DJIDJI
$49145.23-0.00%
^IXICNASDAQ
$24655.74-0.01%
BTCBitcoin
$76184.00-0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$84.52-0.01%
NOKNokia
$11.30+0.05%
POETPoet Technologies
$8.03+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$60.74-0.03%

Questions About TRAX

What is the current price of First Tracks Biotherapeutics?

First Tracks Biotherapeutics is trading at $20.05 per share.

What is the 52-week range for First Tracks Biotherapeutics?

Over the past 52 weeks, First Tracks Biotherapeutics has traded between $14.79 and $26.80.

How much debt does First Tracks Biotherapeutics have?

First Tracks Biotherapeutics total debt is unavailable.

How much cash does First Tracks Biotherapeutics have on hand?

First Tracks Biotherapeutics does not have cash on hand data available.

What is First Tracks Biotherapeutics’s dividend yield?

First Tracks Biotherapeutics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services